Burkitt's lymphoma is a highly aggressive B-cell non-Hodgkin lymphoma and is the fastest
growing human tumour. The disease is associated with Epstein-Barr virus and was one of …

Despite the immune reconstitution promoted by combined antiretroviral therapy (cART),
lymphomas still represent the most common type of cancer in HIV-infected individuals …

Background The relative roles of immunodeficiency, HIV viral load, and combination
antiretroviral therapy (cART) in the onset of individual cancers have rarely been examined …

Background Lymphoma is the leading cause of cancer-related death among HIV-infected
patients in the antiretroviral therapy (ART) era. Methods We studied lymphoma patients in …

Background. We examined durable viral suppression, cumulative viral load (VL) burden,
and transmission risk potential among human immunodeficiency virus (HIV)–diagnosed …

Background. Cross-sectional plasma human immunodeficiency virus (HIV) viral load (VL)
measures have proven invaluable for clinical and research purposes. However, cross …

Background: Viral suppression is a primary marker of HIV treatment success. Persons with
HIV are at increased risk for AIDS-defining cancer (ADC) and several types of non–AIDS …

The intersection and syndemic interaction between the human immunodeficiency virus (HIV)
and tuberculosis (TB) epidemics have global prevalence with devastating morbidity and …

Background Research is needed to better understand relations between
immunosuppression and HIV viraemia and risk for non-Hodgkin lymphoma, a common …

HIV-infected persons treated with highly active antiretroviral therapy (HAART) continue to
have elevated risk for non-Hodgkin lymphoma (NHL). We conducted a retrospective cohort …